FINWIRES · TerminalLIVE
FINWIRES

Navan's Revenue Model Positioned to Benefit From Persistent Travel Inflation, Morgan Stanley Says

By

Navan's (NAVN) revenue model is structurally positioned to benefit from persistent travel inflation as per-trip fees are priced as a percentage of overall ticket value, meaning rising airfares, hotel rates will directly benefit gross booking volume, revenue, Morgan Stanley said in a Tuesday note.

Morgan Stanley further said that the company's fiscal 2027 total revenue guidance of 24% growth is "conservative." With net new gross booking volume growing over 50% in Q4, Morgan Stanley said it expects fiscal 2027 revenue growth in the mid-to-high 20s range with a bull case of 30% and above "increasingly plausible."

Regarding potential artificial intelligence risks, Morgan Stanley said that Navan's strongest moat is its proprietary global travel content and supplier contracts that were built over a decade through one-to-one negotiations.

The company has also been active in AI product development, with its Ava chatbot contributing about 1,100 basis points improvement in its adjusted gross profit margins over the past two years, Morgan Stanley said, adding that AI is now also accelerating revenue through natural-language flight booking features.

Morgan Stanley raised its price target on Navan to $25 from $20 and kept its overweight rating.

Price: $18.73, Change: $+0.39, Percent Change: +2.10%

Related Articles

Wire

IAC Q1 Loss Narrows, Revenue Falls; Shares Drop After Hours

IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.

$IAC
Wire

Vornado Realty Trust Q1 Non-GAAP FFO, Revenue Fall; Shares Drop After Hours

Vornado Realty Trust (VNO) reported Q1 non-GAAP funds from operations late Monday of $0.52 per diluted share, down from $0.63 a year earlier.Analysts polled by FactSet expected $0.51.Revenue in the three months ended March 31 fell to $459.1 million from $461.6 million a year earlier.Analysts surveyed by FactSet expected $431.7 million.Vornado shares fell 3% in after-hours trading.

$VNO
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS